Background. A 48-year-old man presented with diarrhea, flushing, abdominal pain and weight loss of 10 kg over a 6-month period. He subsequently developed dyspnea on exertion. Diagnosis. Carcinoid ...

LONDON, GREATER LONDON, UNITED KINGDOM, February 25, 2025 /EINPresswire / -- How Has The Gastric Cancer Market Size Evolved In Recent Years And What Is Its Growth Potential? The gastric cancer ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...

Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine ...

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs.

Endoscopic submucosal dissection or ESD is an advanced endoscopic procedure that allows for the complete removal of early tumors and cancers of the esophagus, stomach and rectum. In 2015, trained ...